Vigadexa

Vigadexa Drug Interactions

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Drug Interactions
Concomitant use of topical steroids and topical NSAIDs may increase the potential for corneal healing problems.
CYP3A4 inhibitors, including ritonavir and cobicistat, may increase systemic exposure resulting in increased risk of adrenal suppression/Cushing's syndrome (see Precautions.) The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid effects.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in